237 related articles for article (PubMed ID: 16887988)
1. Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1.
Carter RW; Thompson C; Reid DM; Wong SY; Tough DF
J Immunol; 2006 Aug; 177(4):2276-84. PubMed ID: 16887988
[TBL] [Abstract][Full Text] [Related]
2. Concomitant activation and antigen uptake via human dectin-1 results in potent antigen-specific CD8+ T cell responses.
Ni L; Gayet I; Zurawski S; Duluc D; Flamar AL; Li XH; O'Bar A; Clayton S; Palucka AK; Zurawski G; Banchereau J; Oh S
J Immunol; 2010 Sep; 185(6):3504-13. PubMed ID: 20729328
[TBL] [Abstract][Full Text] [Related]
3. Induction of CD8+ T cell responses through targeting of antigen to Dectin-2.
Carter RW; Thompson C; Reid DM; Wong SY; Tough DF
Cell Immunol; 2006 Feb; 239(2):87-91. PubMed ID: 16781694
[TBL] [Abstract][Full Text] [Related]
4. Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses.
Flacher V; Tripp CH; Haid B; Kissenpfennig A; Malissen B; Stoitzner P; Idoyaga J; Romani N
J Immunol; 2012 Mar; 188(5):2146-55. PubMed ID: 22291181
[TBL] [Abstract][Full Text] [Related]
5. Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes.
Schloss J; Ali R; Babad J; Guerrero-Ros I; Pongsachai J; He LZ; Keler T; DiLorenzo TP
Immunohorizons; 2019 Jun; 3(6):236-253. PubMed ID: 31356169
[TBL] [Abstract][Full Text] [Related]
6. Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy.
Flacher V; Sparber F; Tripp CH; Romani N; Stoitzner P
Cancer Immunol Immunother; 2009 Jul; 58(7):1137-47. PubMed ID: 18677477
[TBL] [Abstract][Full Text] [Related]
7. Molecular and functional characterization of human Dectin-1.
Grünebach F; Weck MM; Reichert J; Brossart P
Exp Hematol; 2002 Nov; 30(11):1309-15. PubMed ID: 12423684
[TBL] [Abstract][Full Text] [Related]
8. Dectin-1 Positive Dendritic Cells Expand after Infection with
Zimara N; Chanyalew M; Aseffa A; van Zandbergen G; Lepenies B; Schmid M; Weiss R; Rascle A; Wege AK; Jantsch J; Schatz V; Brown GD; Ritter U
Front Immunol; 2018; 9():263. PubMed ID: 29535708
[TBL] [Abstract][Full Text] [Related]
9. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells.
Yamazaki S; Dudziak D; Heidkamp GF; Fiorese C; Bonito AJ; Inaba K; Nussenzweig MC; Steinman RM
J Immunol; 2008 Nov; 181(10):6923-33. PubMed ID: 18981112
[TBL] [Abstract][Full Text] [Related]
10. Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells.
Yin W; Gorvel L; Zurawski S; Li D; Ni L; Duluc D; Upchurch K; Kim J; Gu C; Ouedraogo R; Wang Z; Xue Y; Joo H; Gorvel JP; Zurawski G; Oh S
EBioMedicine; 2016 Mar; 5():46-58. PubMed ID: 27077111
[TBL] [Abstract][Full Text] [Related]
11. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.
Adams EW; Ratner DM; Seeberger PH; Hacohen N
Chembiochem; 2008 Jan; 9(2):294-303. PubMed ID: 18186095
[TBL] [Abstract][Full Text] [Related]
12. Enhanced dendritic cell-induced immune responses mediated by the novel C-type lectin receptor mDCAR1.
Kaden SA; Kurig S; Vasters K; Hofmann K; Zaenker KS; Schmitz J; Winkels G
J Immunol; 2009 Oct; 183(8):5069-78. PubMed ID: 19786536
[TBL] [Abstract][Full Text] [Related]
13. Directly transfected langerin+ dermal dendritic cells potentiate CD8+ T cell responses following intradermal plasmid DNA immunization.
Elnekave M; Furmanov K; Nudel I; Arizon M; Clausen BE; Hovav AH
J Immunol; 2010 Sep; 185(6):3463-71. PubMed ID: 20713888
[TBL] [Abstract][Full Text] [Related]
14. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses.
Leibundgut-Landmann S; Osorio F; Brown GD; Reis e Sousa C
Blood; 2008 Dec; 112(13):4971-80. PubMed ID: 18818389
[TBL] [Abstract][Full Text] [Related]
16. Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.
Tsuji T; Matsuzaki J; Kelly MP; Ramakrishna V; Vitale L; He LZ; Keler T; Odunsi K; Old LJ; Ritter G; Gnjatic S
J Immunol; 2011 Jan; 186(2):1218-27. PubMed ID: 21149605
[TBL] [Abstract][Full Text] [Related]
17. A novel CD4-CD8alpha+CD205+CD11b- murine spleen dendritic cell line: establishment, characterization and functional analysis in a model of vaccination to toxoplasmosis.
Ruiz S; Beauvillain C; Mévélec MN; Roingeard P; Breton P; Bout D; Dimier-Poisson I
Cell Microbiol; 2005 Nov; 7(11):1659-71. PubMed ID: 16207252
[TBL] [Abstract][Full Text] [Related]
18. Langerin+ dermal dendritic cells are critical for CD8+ T cell activation and IgH γ-1 class switching in response to gene gun vaccines.
Stoecklinger A; Eticha TD; Mesdaghi M; Kissenpfennig A; Malissen B; Thalhamer J; Hammerl P
J Immunol; 2011 Feb; 186(3):1377-83. PubMed ID: 21187444
[TBL] [Abstract][Full Text] [Related]
19. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells.
Unger WW; van Beelen AJ; Bruijns SC; Joshi M; Fehres CM; van Bloois L; Verstege MI; Ambrosini M; Kalay H; Nazmi K; Bolscher JG; Hooijberg E; de Gruijl TD; Storm G; van Kooyk Y
J Control Release; 2012 May; 160(1):88-95. PubMed ID: 22366522
[TBL] [Abstract][Full Text] [Related]
20. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
